ir.celladon.com
Investor Relations - CelladonThe Investor Relations website contains information about Celladon business for stockholders, potential investors, and financial analysts.
http://ir.celladon.com/
The Investor Relations website contains information about Celladon business for stockholders, potential investors, and financial analysts.
http://ir.celladon.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
1.9 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
5
SITE IP
206.200.251.19
LOAD TIME
1.922 sec
SCORE
6.2
Investor Relations - Celladon | ir.celladon.com Reviews
https://ir.celladon.com
The Investor Relations website contains information about Celladon business for stockholders, potential investors, and financial analysts.
ir.celladon.com
Corporate Governance - Celladon
http://ir.celladon.com/corporate-governance.cfm
Stem Cell Factor (mSCF) Gene Therapy Program. Annual Reports and Proxies. Mar 21, 2016. Celladon Announces Results of Special Meeting. Mar 9, 2016. ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger. 124; Terms and Conditions. File is in Briefcase. Nominating and Corporate Governance Committee Charter. File is in Briefcase. File is in Briefcase. Code of Business Conduct and Ethics. File is in Briefcase. Add file to Briefcase.
Investor Relations - Celladon
http://ir.celladon.com/index.cfm
Stem Cell Factor (mSCF) Gene Therapy Program. Annual Reports and Proxies. Mar 21, 2016. Celladon Announces Results of Special Meeting. Mar 9, 2016. ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger. 124; Terms and Conditions. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Celladon's financial performance into perspective. Mar 21, 2016. Mar 9, 2016.
Management - Celladon
http://ir.celladon.com/management.cfm
Stem Cell Factor (mSCF) Gene Therapy Program. Annual Reports and Proxies. Mar 21, 2016. Celladon Announces Results of Special Meeting. Mar 9, 2016. ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger. 124; Terms and Conditions. President and Chief Executive Officer. Elizabeth E. Reed. Vice President and General Counsel.
Press Releases - Celladon
http://ir.celladon.com/releases.cfm
Stem Cell Factor (mSCF) Gene Therapy Program. Annual Reports and Proxies. Mar 21, 2016. Celladon Announces Results of Special Meeting. Mar 9, 2016. ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger. 124; Terms and Conditions. Mar 21, 2016. Celladon Announces Results of Special Meeting. File is in Briefcase. Mar 9, 2016. ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger. File is in Briefcase. Feb 10, 2016. SAN DIEGO, Feb....
Events & Presentations - Celladon
http://ir.celladon.com/events.cfm
Stem Cell Factor (mSCF) Gene Therapy Program. Annual Reports and Proxies. Mar 21, 2016. Celladon Announces Results of Special Meeting. Mar 9, 2016. ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger. 124; Terms and Conditions. Apr 27, 2015. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Nov 17, 2014. File is in Briefcase. Mar 21, 2016. Location: 12255 El Camino Real, Suite 300, San Diego, California 92130.
TOTAL PAGES IN THIS WEBSITE
20
MyDx, Inc. (MYDX)
MyDx Names Tom Gruber as New CEO. Jul 16, 2015. Jan 31, 2015. Sign up for email alerts. Be the first to receive breaking news. Officers & Directors. Chairman, Interim Chief Executive Officer and Chief Innovation Officer. Daniel Yazbeck is a leading science, business and technology professional with nearly 15 years of experience guiding a variety of Fortune 500 companies. He has worked with Pfizer Pharmaceuticals as a Scientist specializing in chemical… View Full Bio. Chief Financial Officer and Secretary.
CEB - Corporate Overview | What the Best Companies Do™
CEB in the Community. CEB Acquires Australia's CEO Forum Group. CEB Reports Second Quarter Results and Updates 2015 Guidance. Personality Tests And Assessments In The Workplace: Myth Versus Reality. CEB Sets Date for 2015 Second Quarter Conference Call and Webcast. Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources. 160; 0.25. Data as of 08/18/15 2:39 pm ET. Minimum 20 minute delay. Q3 2015 Investor Slide Show. June 2015 Investor Day Presentation.
Commercial Real Estate - Cedar Realty Trust - Real Estate Agents Now Serving the Northeast
Camp Hill, PA. As of August 7, 2015 -. Minimum 20 minute delay. Q2 2015 Cedar Realty Trust Inc Earnings Conference Call. Thursday, August 6, 2015. Cedar Realty Trust, Inc. Cedar Realty Trust Reports Second Quarter 2015 Results. Cedar Realty Trust Declares Dividends On Common And Preferred Stock. Cedar Realty Trust to Report Second Quarter 2015 Financial Results. Cedar Realty Trust Reports First Quarter 2015 Results. Cedar Realty Trust Declares Dividends on Common and Preferred Stock. Cedar Realty Trust D...
Коллекции irCEIk
Подписаться на рассылку обновлений. Репозитарий Высшей школы экономики и бизнеса ФГАОУ ВО "Крымский федеральный университет имени В.И. Вернадского". Электронный архив, который накапливает, сохраняет электронные публикации и электронные версии документов (произведений), созданных сотрудниками Высшей школы экономики и бизнеса ФГАОУ ВО "Крымский федеральный университет имени В.И. Вернадского", а также предоставляет бесплатный полнотекстовый доступ к ним из сети Интернет. Материалы конференций [ 2.
Investor Relations - Celgene Corporation
Committed to improving the lives of patients worldwide. Skip to primary content. Research & Development. Research & Development. Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Our portfolio of commercial products include REVLIMID. Mar 28, 2018. Mar 6, 2018. View all press releases ». Featured Events and Presentations. Annual Report and Proxy.
Investor Relations - Celladon
Hope to Heart Patients. Stem Cell Factor (mSCF) Gene Therapy Program. Annual Reports and Proxies. Aug 11, 2015. Celladon Reports Second Quarter 2015 Financial Results. Jun 26, 2015. Celladon Corporation Provides Business Update. 124; Terms and Conditions. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Celladon's financial performance into perspective. Aug 11, 2015. Jun 26, 2015.
セントラル総合開発
平成28年３月期 第１四半期決算短信 日本基準 連結. 当ホームページにおける文書 写真 動画 ソフトウェア等は、当社ないし第三者が有する知的財産権その他の権利により守られています。
Investor Overview
Grass Seed and Soil Supplements. Weed, Insect and Pest Control. Wild and Pet Bird. Wild and Pet Bird. Corporate and Investor Relations. Vice President of Investor Relations and Communications.
Central Pacific Bank - Corporate Profile
Overdraft Protection / Avoid Overdraft Fees. Mortgage Payment Helpful Tips (PDF). How to Read Your Mortgage Loan Statement (PDF). Finance the purchase and installation of a photovoltaic (PV) system for your home. Online Payroll From ADP. Online Payroll From Ceridian. MasterCard Easy Savings Program. Save automatically whenever you sign or select 'credit' when using your Business Debit MasterCard. Trust and Investment Services. Central Pacific Investment Services. Person to Person Payments. Founded by a s...
Century 21 China Real Estate - Investor Relations - IR Home
Back to Chinese Web page. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Century 21 China Real Estate Reports First Quarter 2015 Unaudited Financial Results. Century 21 China Real Estate Files 2014 Annual Report on Form 20-F and Appoints Grant Thornton as Independent Auditor. Century 21 China Real Estate Reports Fourth Quarter and Fiscal Year 2014 Unaudited Financial Results. Century 21 China Real Estate to Report Fourth Quarter 2014 Financial Results on March 11, 2015. Form 8937 Report of Orga...
SOCIAL ENGAGEMENT